ad image

Real World Evidence

1 / 1
Overcoming Challenges and Unlocking the Potential of Real-World Evidence
Real-World Evidence

Overcoming Challenges and Unlocking the Potential of Real-World Evidence

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-09Mar 02, 2025
Using Artificial Intelligence to Get the Right Drug to the Right Patient at the Right Time
Artificial Intelligence

Using Artificial Intelligence to Get the Right Drug to the Right Patient at the Right Time

Stefan Weiss, M.D.

PAO-05-23-CL-01May 02, 2023
New FDA Guidance on Real World Evidence/Real World Data
Column: Regulatory Spotlight

New FDA Guidance on Real World Evidence/Real World Data

David Alvaro, Ph.D.

Pharma's Almanac

PAO-03-022-NI-03Mar 23, 2022
Janssen Pharmaceutical Companies
Real-World Analysis

XARELTO® Significantly Reduced Ischemic Stroke in Real-World Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulants

Janssen Pharmaceutical Companies

PR-M03-19-NI-044Mar 15, 2019
Understanding the FDA’s Approach to Real-World Evidence
Regulatory Spotlight

Understanding the FDA’s Approach to Real-World Evidence

David Alvaro, Ph.D.

Pharma's Almanac

PAP-Q1-2019-NI-008Mar 12, 2019
1 / 1